ResMed Inc. (RMD) — Stock Price, Chart & Analysis
ResMed Inc. (RMD) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $30.74B and a trailing P/E ratio of 21.49. Over the past 52 weeks, RMD has traded between $180.27 and $293.81. ResMed Inc. pays a dividend yielding 1.1%. View the live RMD chart, technical opinion, analyst ratings, fundamentals and latest news below.
ResMed Inc. (RMD) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $30.74B |
| P/E ratio (TTM) | 21.49 |
| EPS (TTM) | $9.86 |
| Dividend yield | 1.1% |
| 52-week high | $293.81 |
| 52-week low | $180.27 |
| Beta | 0.75 |
| Avg. volume | 1.54M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Frequently asked questions about ResMed Inc. (RMD)
How much does one share of ResMed Inc. cost?
As of the latest update, one share of ResMed Inc. (RMD) trades at $100 (+0.00% today).
What is ResMed Inc.'s market cap?
ResMed Inc. has a market capitalization of approximately $30.74B.
What is ResMed Inc.'s P/E ratio?
ResMed Inc. has a trailing price-to-earnings (P/E) ratio of 21.49.
What is ResMed Inc.'s earnings per share (EPS)?
ResMed Inc.'s trailing twelve-month EPS is $9.86.
Does ResMed Inc. pay a dividend?
Yes — ResMed Inc. pays a dividend with a yield of 1.1% ($2.40 per share annually).
What is ResMed Inc.'s 52-week trading range?
Over the past year, RMD has traded between $180.27 and $293.81.
What is the analyst price target for ResMed Inc.?
The mean analyst price target for ResMed Inc. is $248.33. This is informational only and not investment advice.
Latest ResMed Inc. (RMD) news
- RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/YNews · Aug 7, 2026
- Update: US Equity Futures Rise Pre-Bell as Traders Assess Jobs Report, Monitor Middle East DevelopmentsNews · Aug 7, 2026
- ResMed Shares Fall After Revenue Miss and Conservative 2027 OutlookNews · Aug 7, 2026
- ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...News · Aug 7, 2026
- ResMed (NYSE:RMD) Posts Q2 CY2026 Sales In Line With Estimates But Stock DropsNews · Aug 6, 2026
- ResMed (RMD) Q4 Earnings and Revenues Top EstimatesNews · Aug 6, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live RMD dashboard…